MMPs (Matrix Metalloproteinases) are a family of zinc-dependent endopeptidases involved in the breakdown of extracellular matrix (ECM) components. They play crucial roles in various physiological and pathological processes including tissue remodeling, wound healing, and cancer metastasis. MMPs are classified into several types based on their substrate specificity and domain structure.

Recombinant MMP Protein

Recombinant MMP proteins are produced using recombinant DNA technology. This involves inserting the gene encoding the specific MMP into an expression vector, transforming it into a suitable host cell system, and then expressing and purifying the protein.

Production Process
  • Gene Cloning: The gene encoding the MMP is cloned into an expression vector. This vector may include tags or sequences to aid in the purification process.
  • Transformation: The vector is introduced into a host cell system (e.g., E. coli, yeast, or mammalian cells) using methods such as heat shock, electroporation, or transfection.
  • Expression: The host cells are cultured under conditions that induce the expression of the MMP protein.
  • Purification: The MMP protein is purified from the cell lysate or culture supernatant using chromatography techniques, such as affinity chromatography or ion exchange chromatography, to ensure high purity and functionality.
Structure and Function
  • Structure: MMPs typically contain a propeptide domain, a catalytic domain, and a hemopexin-like domain. The catalytic domain includes a zinc-binding site essential for enzymatic activity.
  • Function: MMPs degrade various ECM components such as collagen, gelatin, and elastin. This activity is crucial for tissue remodeling, development, and repair. Dysregulation of MMP activity is associated with diseases such as arthritis, cancer, and cardiovascular disorders.
Applications
  • Research: Used to study ECM remodeling, cell migration, and tissue repair processes. Recombinant MMPs are essential for understanding the role of matrix degradation in disease progression.
  • Drug Discovery: Assists in screening and developing inhibitors that can modulate MMP activity for therapeutic purposes, particularly in cancer metastasis and tissue fibrosis.
  • Diagnostics: Potential use in assays to measure MMP levels in biological samples, aiding in the diagnosis and monitoring of diseases involving ECM degradation.
Quality Control
  • Purity: Ensured by SDS-PAGE, Western blotting, and HPLC to confirm the absence of contaminants.
  • Activity: Verified through enzymatic assays (e.g., gelatinase or collagenase assays) to ensure the protein retains its catalytic activity.
  • Stability: Assessed under various storage conditions to ensure the protein remains functional and stable over time.

Recombinant MMP proteins are critical tools for studying ECM dynamics and developing therapeutic strategies for diseases associated with abnormal matrix remodeling. Their production and application in research, drug discovery, and diagnostics enhance our understanding of tissue biology and disease mechanisms.

AffiREC® Rat Matrilysin (Mmp7) Recombinant Protein
CAT# AFG-CUB-7329
Size: 100 μg
517.00 517.0 USD
AffiREC® Rat Matrilysin (Mmp7) Recombinant Protein
CAT# AFG-CUB-7328
Size: 100 μg
518.50 518.5 USD
517.00 517.0 USD
518.50 518.5 USD
518.50 518.5 USD
518.50 518.5 USD
437.50 437.5 USD
398.50 398.5 USD
398.50 398.5 USD
1,471.00 1471.0 USD
797.50 797.5 USD
1,193.50 1193.5 USD
398.50 398.5 USD
398.50 398.5 USD
398.50 398.5 USD
398.50 398.5 USD
398.50 398.5 USD
AffiREC® Dog MMP13 (MMP13) Recombinant Protein
CAT# AFG-CUB-0800
Size: 100 μg
631.00 631.0 USD
704.50 704.5 USD
AffiREC® Recombinant Human MMP-2 (C-6His)
CAT# AFG-EPR-0297
Size: 10 µg
237.15 237.15 USD
AffiREC® Recombinant Human MMP-9 (C-6His)
CAT# AFG-EPR-0279
Size: 10 µg
237.15 237.15 USD